Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Brain tumor, adult: Pineal parenchymal tumors
Country:  U.S.A.
Trial Type:  Treatment
Results 1-7 of 7 for your search:
Start Over
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients with Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Phase: Phase II, Phase I
Type: Treatment
Age: 1 to 30
Trial IDs: SOL-08131-L, NCI-2013-00790, 5056, MR00042551, OHSU-5056, NCT00983398
Plerixafor after Radiation Therapy and Temozolomide in Treating Patients with Newly Diagnosed High Grade Glioma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: BRN0023, NCI-2013-02012, NCT01977677
Proton Beam Radiation Therapy in Treating Patients with Medulloblastoma and Pineoblastoma
Phase: Phase II
Type: Treatment
Age: 3 to 25
Trial IDs: DFCI 09-361, NCI-2010-01328, NCT01063114
Donor Bone Marrow Transplant in Treating Patients with High-Risk Solid Tumors
Phase: Phase II
Type: Treatment
Age: 0 to 40
Trial IDs: J12106, NCI-2013-00702, CIR00008429, CIR00009228, NA_00076243, NA_00076243 / CIR00009228, NCT01804634
Temozolomide and Ascorbic Acid in Treating Patients with Recurrent High-Grade Glioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 735-13, NCI-2014-01061, NCT02168270
Vaccine Therapy in Treating Patients With Recurrent Gliomas After Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 08-135, NCI-2011-02491, NCT00874861
Conditioning Therapy Followed by Stem Cell Transplant in Treating Patients with High Risk or Relapsed Solid or Central Nervous System Tumors
Phase: No phase specified
Type: Treatment
Age: 70 and under
Trial IDs: 2011OC057, NCI-2013-02265, 1107M02641, MT2011-09C, NCT01505569
Start Over